93-5 (Naproxen delayed-release 375 mg)

Pill imprint 93-5 has been identified as Naproxen delayed-release 375 mg.

Naproxen is used in the treatment of back pain; ankylosing spondylitis; bursitis; tendonitis; headache (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Naproxen 375 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 93-5

Naproxen delayed-release 375 mg 93-5  Front
Naproxen delayed-release 375 mg 93-5  Back
Naproxen delayed-release 375 mg 93-5
Naproxen delayed-release 375 mg 93-5
Naproxen delayed-release
Imprint:
93-5
Strength:
375 mg
Color:
White
Size:
16.00 mm
Shape:
Elliptical / Oval
Availability:
Rx and/or OTC
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-1005

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)